Suppr超能文献

用于外周动脉疾病治疗的细胞疗法:系统评价与荟萃分析方案

Cellular therapy for the peripheral arterial disease treatment: Protocol for a systematic review and meta-analysis.

作者信息

Rodríguez-Valiente Mónica, Fuente-Mora Cristina, Sánchez-Gálvez Javier, Ortín-Pérez Micaela, Pardo-Ríos Manuel, Sánchez-Sáez José Manuel, Pimenta Isac Davidson Santiago Fernandes, Piuvezam Grasiela, Ramos-Petersen Laura

机构信息

Catholic University San Antonio de Murcia, Murcia, Spain.

Biomedical Research Institute of Murcia (IMIB), Murcia, Spain.

出版信息

PLoS One. 2025 Jan 9;20(1):e0314070. doi: 10.1371/journal.pone.0314070. eCollection 2025.

Abstract

Cellular therapy is a promising treatment option for Peripheral Arterial Disease (PAD). Different cell types can be used to regenerate and repair tissues affected by PAD. Many studies have proposed the use of stem cells, such as mesenchymal stem cells, or even mononuclear cells isolated from peripheral blood or bone marrow, to treat PAD. This paper reports a protocol of systematic review and meta-analysis that aims to identify the effects of stem cell treatment in patients with peripheral arterial disease. The search will be conducted in the following database: PubMed/MEDLINE, Clinicaltrial.gov, Scopus, Embase, Epistemonikos, Web of Science and Cochrane Library. Studies will be selected independently by two reviewers and will include all published randomized and non-randomized clinical trials. The data extraction will include studies population characteristics, type of treatment and main outcomes. We will assess the methodological quality of the studies using the Cochrane Risk of Bias 2.0 and Risk of Bias in Non-randomized Studies of Interventions. The certainty of the evidence will be rate using the Grading of Recommendations, Assessment, Development, and Evaluations. The findings will be presented in narrative summary tables and in a meta-analysis.

摘要

细胞疗法是外周动脉疾病(PAD)一种很有前景的治疗选择。不同类型的细胞可用于再生和修复受PAD影响的组织。许多研究提出使用干细胞,如间充质干细胞,甚至从外周血或骨髓中分离出的单核细胞来治疗PAD。本文报告了一项系统评价和荟萃分析方案,旨在确定干细胞治疗对外周动脉疾病患者的影响。检索将在以下数据库中进行:PubMed/MEDLINE、Clinicaltrial.gov、Scopus、Embase、Epistemonikos、Web of Science和Cochrane图书馆。研究将由两名 reviewers 独立选择,将包括所有已发表的随机和非随机临床试验。数据提取将包括研究人群特征、治疗类型和主要结局。我们将使用Cochrane偏倚风险2.0和干预非随机研究中的偏倚风险来评估研究的方法学质量。证据的确定性将使用推荐分级、评估、制定和评价进行评级。研究结果将以叙述性汇总表和荟萃分析的形式呈现。

相似文献

6
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
7
Gene therapy for peripheral arterial disease.外周动脉疾病的基因治疗
Cochrane Database Syst Rev. 2018 Oct 31;10(10):CD012058. doi: 10.1002/14651858.CD012058.pub2.

本文引用的文献

2
Therapeutic potential of mesenchymal stem cells for diabetes.间充质干细胞在糖尿病治疗中的潜力
J Mol Endocrinol. 2017 Oct;59(3):R109-R120. doi: 10.1530/JME-17-0117. Epub 2017 Jul 24.
3
Critical Limb Ischemia: Current Trends and Future Directions.严重肢体缺血:当前趋势与未来方向
J Am Heart Assoc. 2016 Feb 23;5(2):e002938. doi: 10.1161/JAHA.115.002938.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验